安普克
二甲双胍
糖尿病
医学
蛋白激酶A
异三聚体G蛋白
AMP活化蛋白激酶
药理学
信号转导
人口
白藜芦醇
内分泌学
内科学
生物
激酶
G蛋白
细胞生物学
受体
环境卫生
作者
Tanuj Joshi,Amit Kumar Singh,Pouya Haratipour,Archana N. Sah,Abhay K. Pandey,Rozita Naseri,Vijay Juyal,Mohammad Hosein Farzaei
摘要
Abstract Diabetes affects a large population of the world. Lifestyle, obesity, dietary habits, and genetic factors contribute to this metabolic disease. A target pathway to control diabetes is the 5′‐adenosine monophosphate‐activated protein kinase (AMPK) signaling pathway. AMPK is a heterotrimeric protein with α, β, and γ subunits. In several studies, AMPK activation enhanced glucose uptake into cells and inhibited intracellular glucose production. Impairment of AMPK activity is present in diabetes, according to some studies. Drugs used in the treatment of diabetes, such as metformin, are also known to act through regulation of AMPK. Thus, drugs that activate and regulate AMPK are potential candidates for the treatment of diabetes. In addition, many patients encounter important adverse effects, like hypoglycemia, while using allopathic drugs. As a result, the investigation of plant‐derived natural drugs that lack adverse side effects and treat diabetes is necessary. Natural products like berberine, quercetin, resveratrol, and so forth have shown significant potential in regulating and activating the AMPK pathway which can lead to manage diabetes mellitus and its complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI